Alethia Young
Stock Analyst at William Blair
(1.42)
# 3,707
Out of 5,136 analysts
14
Total ratings
46.2%
Success rate
-1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Alethia Young
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLDB Solid Biosciences | Initiated Coverage: Buy | $11 | $6.48 | +69.75% | 1 | Nov 9, 2026 | |
| PVLA Palvella Therapeutics | Reiterated: Buy | n/a | $144.60 | - | 2 | Oct 28, 2026 | |
| CYTK Cytokinetics | Initiated Coverage: Buy | n/a | $53.17 | - | 1 | Oct 15, 2026 | |
| EWTX Edgewise Therapeutics | Initiated Coverage: Buy | $53 | $43.68 | +21.34% | 1 | Oct 15, 2026 | |
| FTH Faeth Therapeutics | Initiated Coverage: Buy | $66 | $9.28 | +611.21% | 1 | Oct 15, 2026 | |
| IDYA IDEAYA Biosciences | Initiated Coverage: Buy | $51 | $30.36 | +67.98% | 1 | Oct 15, 2026 | |
| IMNM Immunome | Initiated Coverage: Buy | $35 | $17.61 | +98.75% | 1 | Oct 15, 2026 | |
| KARD Kardigan | Initiated Coverage: Buy | $38 | $12.85 | +195.72% | 1 | Oct 15, 2026 | |
| RCUS Arcus Biosciences | Initiated Coverage: Buy | $50 | $16.86 | +196.56% | 1 | Oct 15, 2026 | |
| RVMD Revolution Medicines | Initiated Coverage: Buy | $226 | $166.87 | +35.43% | 1 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $206 | $107.48 | +91.66% | 1 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $24.17 | +73.77% | 1 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8.37 | $2.87 | +191.64% | 1 | Oct 15, 2026 |
Solid Biosciences
Nov 9, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $6.48
Upside: +69.75%
Palvella Therapeutics
Oct 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $144.60
Upside: -
Cytokinetics
Oct 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $53.17
Upside: -
Edgewise Therapeutics
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $53
Current: $43.68
Upside: +21.34%
Faeth Therapeutics
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $66
Current: $9.28
Upside: +611.21%
IDEAYA Biosciences
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $51
Current: $30.36
Upside: +67.98%
Immunome
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $17.61
Upside: +98.75%
Kardigan
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $38
Current: $12.85
Upside: +195.72%
Arcus Biosciences
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $50
Current: $16.86
Upside: +196.56%
Revolution Medicines
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $226
Current: $166.87
Upside: +35.43%
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $206
Current: $107.48
Upside: +91.66%
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $24.17
Upside: +73.77%
Oct 15, 2026
Initiated Coverage: Buy
Price Target: $8.37
Current: $2.87
Upside: +191.64%